NCT01739062View on ClinicalTrials.gov

The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice

NAActive, not recruitingINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2031

Conditions
Prostate Cancer
Interventions
GENETIC

Genetic risk assessment

Trial Locations (1)

8200

Department of Molecular Medicine, Aarhus N

All Listed Sponsors
collaborator

Velux Fonden

OTHER

collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT01739062 - The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice | Biotech Hunter | Biotech Hunter